PCM
CLOV icon

Prelude Capital Management’s Clover Health Investments CLOV Stock Holding History

Prelude Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,732
Closed -$70K – 1832
2022
Q1 		$70K Buy
+19,732
New +$57.2K ﹤0.01% 1460

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Prelude Capital Management's CLOV Position: Q2 2022 in Review

Prelude Capital Management sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 19,732 shares — an estimated $70K sold.

Prelude Capital Management first reported a position in CLOV in Q1 2022 and held it in 1 quarter. The position peaked at $70K in Q1 2022. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Prelude Capital Management reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Prelude Capital Management sold 19,732 Clover Health Investments shares in Q2 2022, an estimated $70K.
  • Prelude Capital Management first reported a position in Clover Health Investments in Q1 2022 and held it in 1 quarter.
  • Prelude Capital Management's Clover Health Investments position peaked at $70K in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Prelude Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.